Literature DB >> 8254757

Human immunodeficiency virus type 1 envelope glycoprotein is modified by O-linked oligosaccharides.

H B Bernstein1, S P Tucker, E Hunter, J S Schutzbach, R W Compans.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein has been shown to be extensively modified by N-linked glycosylation; however, the presence of O-linked carbohydrates on the glycoprotein has not been firmly established. We have found that enzymatic deglycosylation of the HIV-1 envelope glycoprotein with neuraminidase and O-glycosidase results in a decrease in the apparent molecular weight of the envelope glycoprotein. This result was observed in both vaccinia virus recombinant-derived envelope glycoproteins and glycoproteins derived from the IIIB, SG3, and HXB2, strains of HIV-1. The decrease in molecular weight was also observed when the envelope glycoprotein had been deglycosylated with N-glycanase F after treatment with neuraminidase and O-glycosidase, indicating that the decrease in apparent molecular weight was not attributable to the removal of N-linked carbohydrate. Treatment with neuraminidase, O-glycosidase, and N-glycanase F was found to be necessary to remove all radiolabel from [3H]glucosamine-labelled envelope glycoprotein, a result seen for both recombinant and HIV-1-derived envelope glycoprotein. [3H]glucosamine-labelled carbohydrates liberated by O-glycosidase treatment were separated by paper chromatography and were found to be of a size consistent with O-linked oligosaccharides. We, therefore, conclude that the HIV-1 envelope glycoprotein is modified by the addition of O-linked carbohydrates.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8254757      PMCID: PMC236307     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Human immunodeficiency virus glycoproteins: lectin binding properties.

Authors:  L Hammar; S Eriksson; B Morein
Journal:  AIDS Res Hum Retroviruses       Date:  1989-10       Impact factor: 2.205

2.  Biosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: effects of monensin on glycosylation and transport.

Authors:  R L Dewar; M B Vasudevachari; V Natarajan; N P Salzman
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

Review 3.  Glycoproteins: what are the sugar chains for?

Authors:  J C Paulson
Journal:  Trends Biochem Sci       Date:  1989-07       Impact factor: 13.807

Review 4.  Separation and analysis of glycoprotein oligosaccharides.

Authors:  R D Cummings; R K Merkle; N L Stults
Journal:  Methods Cell Biol       Date:  1989       Impact factor: 1.441

5.  Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein 120.

Authors:  H Geyer; C Holschbach; G Hunsmann; J Schneider
Journal:  J Biol Chem       Date:  1988-08-25       Impact factor: 5.157

6.  Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160.

Authors:  R L Willey; J S Bonifacino; B J Potts; M A Martin; R D Klausner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

7.  Biochemical characterization of cell-associated and extracellular products of the Friend spleen focus-forming virus env gene.

Authors:  A Pinter; W J Honnen
Journal:  Virology       Date:  1989-11       Impact factor: 3.616

8.  Effects of deletion of the cytoplasmic domain upon surface expression and membrane stability of a viral envelope glycoprotein.

Authors:  D R Kilpatrick; R V Srinivas; E B Stephens; R W Compans
Journal:  J Biol Chem       Date:  1987-11-25       Impact factor: 5.157

9.  Glycosylation and processing of the human immunodeficiency virus type 1 envelope protein.

Authors:  K Kozarsky; M Penman; L Basiripour; W Haseltine; J Sodroski; M Krieger
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1989

10.  A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes.

Authors:  S K Ghosh; P N Fultz; E Keddie; M S Saag; P M Sharp; B H Hahn; G M Shaw
Journal:  Virology       Date:  1993-06       Impact factor: 3.616

View more
  39 in total

1.  Role of N-linked glycosylation of the Hendra virus fusion protein.

Authors:  James Richard Carter; Cara Theresia Pager; Stephen Derrick Fowler; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

2.  Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies.

Authors:  B Chackerian; L M Rudensey; J Overbaugh
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Replication of HIV-1 envelope protein cytoplasmic domain variants in permissive and restrictive cells.

Authors:  August O Staubus; Ayna Alfadhli; Robin Lid Barklis; Eric Barklis
Journal:  Virology       Date:  2019-09-18       Impact factor: 3.616

4.  NetOglyc: prediction of mucin type O-glycosylation sites based on sequence context and surface accessibility.

Authors:  J E Hansen; O Lund; N Tolstrup; A A Gooley; K L Williams; S Brunak
Journal:  Glycoconj J       Date:  1998-02       Impact factor: 2.916

5.  Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein.

Authors:  J P Moore; J Sodroski
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

6.  Virus isolates during acute and chronic human immunodeficiency virus type 1 infection show distinct patterns of sensitivity to entry inhibitors.

Authors:  Peter Rusert; Herbert Kuster; Beda Joos; Benjamin Misselwitz; Cornelia Gujer; Christine Leemann; Marek Fischer; Gabriela Stiegler; Hermann Katinger; William C Olson; Rainer Weber; Leonardo Aceto; Huldrych F Günthard; Alexandra Trkola
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

7.  Identification of replication-competent strains of simian immunodeficiency virus lacking multiple attachment sites for N-linked carbohydrates in variable regions 1 and 2 of the surface envelope protein.

Authors:  J N Reitter; R C Desrosiers
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

8.  Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses.

Authors:  Yun Li; Bradley Cleveland; Igor Klots; Bruce Travis; Barbra A Richardson; David Anderson; David Montefiori; Patricia Polacino; Shiu-Lok Hu
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

Review 9.  The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.

Authors:  Thomas S Postler; Ronald C Desrosiers
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

Review 10.  Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA.

Authors:  Jean-Philippe Julien; Peter S Lee; Ian A Wilson
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.